Onward Medical N.V. (EBR:ONWD)
1.454
-0.062 (-4.09%)
Nov 19, 2026, 5:35 PM CET
Onward Medical Stock Forecast
EBR-ONWD's stock price has decreased by -64.96% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
According to 5 analysts polled by S&P Global, Onward Medical stock has a consensus rating of "Strong Buy" and an average price target of €7.86. The average 1-year stock price forecast is 440.58% higher than the current stock price, while the lowest is €5.40 (+271.39%) and the highest is €10.10 (+594.64%).
Price Target: €7.86 (+440.58%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Onward Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Apr '26 | May '26 | Jun '26 | Sep '26 | Oct '26 | Nov '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 5 |
Financial Forecast
Revenue This Year
10.01M
from 5.41M
Increased by 84.90%
Revenue Next Year
23.73M
from 10.01M
Increased by 137.04%
EPS This Year
-0.83
from -0.90
EPS Next Year
-0.71
from -0.83
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.